SFCM
AVTX icon

Seven Fleet Capital Management’s Avalo Therapeutics AVTX Stock Holding History

Seven Fleet Capital Management’s Portfolio AVTX Stock Details AVTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.2M Buy
770,765
+556,946
+260% +$8.8M 2.35% 8
2026
Q1 		$3.19M Buy
213,819
+150,476
+238% +$2.35M 1% 25
2025
Q4 		$1.15M Buy
+63,343
New +$1.07M 0.78% 24

Other funds holding AVTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Seven Fleet Capital Management's AVTX Position: Q2 2026 in Review

Seven Fleet Capital Management increased its Avalo Therapeutics (AVTX) stake by 260% in Q2 2026, buying an estimated $8.8M and bringing the position to 770,765 shares worth $14.2M. The position accounts for 2.35% of the portfolio, ranked #8.

Seven Fleet Capital Management first reported a position in AVTX in Q4 2025 and has held it in 3 quarters since. 125 funds tracked by Wall St. Rank hold AVTX as of Q2 2026.

  • Seven Fleet Capital Management held 770,765 shares of Avalo Therapeutics worth $14.2M as of Q2 2026.
  • Seven Fleet Capital Management bought 556,946 Avalo Therapeutics shares in Q2 2026, an estimated $8.8M.
  • Avalo Therapeutics made up 2.35% of Seven Fleet Capital Management's portfolio in Q2 2026, its #8 holding.
  • Seven Fleet Capital Management first reported a position in Avalo Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • 125 funds tracked by Wall St. Rank held Avalo Therapeutics as of Q2 2026.

Based on Seven Fleet Capital Management's 13F filing for Q2 2026, filed 17 Aug 2026.